Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Feb 2026 for Organogenesis Holdings Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Michele Ilene Korfin: trading record in brief
This profile gathers the share dealings of Michele Ilene Korfin across 2 companies, led by Organogenesis Holdings Inc. and Gamida Cell Ltd. We count 8 filings; the first trade dates from 28 January 2022 and the latest from 18 February 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 20 February 2026: a share grant, in Organogenesis Holdings Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michele Ilene Korfin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
48,828 shares0Class A Common StockSEC:0002064832-26-000049:0
49,575 shares0Class A Common StockSEC:0001062993-25-003214:0
51,020 shares0Class A Common StockSEC:0001062993-24-004308:0
480,319 shares0Ordinary SharesSEC:0001415889-24-002306:0
65,737 shares0Class A Common StockSEC:0001062993-23-004884:0
92,990 shares0Ordinary SharesSEC:0001209191-23-008562:0
23,913 shares0Class A Common StockSEC:0001062993-22-011683:0
63,800 shares0Ordinary SharesSEC:0001209191-22-005908:0
8 of 8 declarations
